Global Antiasthmatic Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Page: 113
Published Date: 26 Jul 2021
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Antiasthmatic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antiasthmatic Drug size is estimated to be USD XX million in 2026 from USD XX million in 2020, with a change XX% between 2020 and 2021. The global Antiasthmatic Drug market size is expected to grow at a CAGR of XX% for the next five years.
Market segmentation
Antiasthmatic Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bronchodilators
Anti-allergic Antiasthmatic
Anti-inflammatory Antiasthmatic
Market segment by Application, can be divided into
Need for Acute Attack of Asthma
Treatment of Chronic Asthma
Market segment by players, this report covers
Novartis AG
GlaxoSmithKline
ABC Farmaceutici Spa
AstraZeneca
Teva Pharmaceutical Industries Ltd
Mundipharma Pharmaceuticals Ltd.
MSD
Daiichi Sankyo Company Limited
Chiesi GmbH
Kyorin Pharmaceutical Co.,Ltd.
Kissei Pharmaceutical Co.Ltd.
Ruiyang Pharmaceutical Co., Ltd
Chiesi Pharmaceutical (Shangai) Co., Ltd
Fuhe Group
Lunan Pharmaceutical Group Co., Ltd
Chengdu Huayu Pharmaceutical Co., Ltd
Kaifeng Kangnuo Pharmaceutical Co., Ltd
Akorn Pharmaceutical Co.Ltd.
Boehringer Ingelheim Pharma GmbH&Co.KG
Covis Pharmaceutical Inc
Roche
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Antiasthmatic Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Antiasthmatic Drug, with revenue, gross margin and global market share of Antiasthmatic Drug from 2019 to 2021.
Chapter 3, the Antiasthmatic Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Antiasthmatic Drug market forecast, by regions, way of action and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Antiasthmatic Drug research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Antiasthmatic Drug
1.2 Classification of Antiasthmatic Drug by Way of Action
1.2.1 Overview: Global Antiasthmatic Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Antiasthmatic Drug Revenue Market Share by Type in 2020
1.2.3 Bronchodilators
1.2.4 Anti-allergic Antiasthmatic
1.2.5 Anti-inflammatory Antiasthmatic
1.3 Global Antiasthmatic Drug Market by Application
1.3.1 Overview: Global Antiasthmatic Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Need for Acute Attack of Asthma
1.3.3 Treatment of Chronic Asthma
1.4 Global Antiasthmatic Drug Market Size & Forecast
1.5 Global Antiasthmatic Drug Market Size and Forecast by Region
1.5.1 Global Antiasthmatic Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Antiasthmatic Drug Market Size by Region, (2016-2021)
1.5.3 North America Antiasthmatic Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Antiasthmatic Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Antiasthmatic Drug Market Size and Prospect (2016-2026)
1.5.6 South America Antiasthmatic Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Antiasthmatic Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Antiasthmatic Drug Market Drivers
1.6.2 Antiasthmatic Drug Market Restraints
1.6.3 Antiasthmatic Drug Trends Analysis
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Antiasthmatic Drug Product and Solutions
2.1.4 Novartis AG Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis AG Recent Developments and Future Plans
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Antiasthmatic Drug Product and Solutions
2.2.4 GlaxoSmithKline Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GlaxoSmithKline Recent Developments and Future Plans
2.3 ABC Farmaceutici Spa
2.3.1 ABC Farmaceutici Spa Details
2.3.2 ABC Farmaceutici Spa Major Business
2.3.3 ABC Farmaceutici Spa Antiasthmatic Drug Product and Solutions
2.3.4 ABC Farmaceutici Spa Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 ABC Farmaceutici Spa Recent Developments and Future Plans
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Antiasthmatic Drug Product and Solutions
2.4.4 AstraZeneca Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 AstraZeneca Recent Developments and Future Plans
2.5 Teva Pharmaceutical Industries Ltd
2.5.1 Teva Pharmaceutical Industries Ltd Details
2.5.2 Teva Pharmaceutical Industries Ltd Major Business
2.5.3 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product and Solutions
2.5.4 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
2.6 Mundipharma Pharmaceuticals Ltd.
2.6.1 Mundipharma Pharmaceuticals Ltd. Details
2.6.2 Mundipharma Pharmaceuticals Ltd. Major Business
2.6.3 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product and Solutions
2.6.4 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Mundipharma Pharmaceuticals Ltd. Recent Developments and Future Plans
2.7 MSD
2.7.1 MSD Details
2.7.2 MSD Major Business
2.7.3 MSD Antiasthmatic Drug Product and Solutions
2.7.4 MSD Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 MSD Recent Developments and Future Plans
2.8 Daiichi Sankyo Company Limited
2.8.1 Daiichi Sankyo Company Limited Details
2.8.2 Daiichi Sankyo Company Limited Major Business
2.8.3 Daiichi Sankyo Company Limited Antiasthmatic Drug Product and Solutions
2.8.4 Daiichi Sankyo Company Limited Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Daiichi Sankyo Company Limited Recent Developments and Future Plans
2.9 Chiesi GmbH
2.9.1 Chiesi GmbH Details
2.9.2 Chiesi GmbH Major Business
2.9.3 Chiesi GmbH Antiasthmatic Drug Product and Solutions
2.9.4 Chiesi GmbH Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Chiesi GmbH Recent Developments and Future Plans
2.10 Kyorin Pharmaceutical Co.,Ltd.
2.10.1 Kyorin Pharmaceutical Co.,Ltd. Details
2.10.2 Kyorin Pharmaceutical Co.,Ltd. Major Business
2.10.3 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product and Solutions
2.10.4 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Kyorin Pharmaceutical Co.,Ltd. Recent Developments and Future Plans
2.11 Kissei Pharmaceutical Co.Ltd.
2.11.1 Kissei Pharmaceutical Co.Ltd. Details
2.11.2 Kissei Pharmaceutical Co.Ltd. Major Business
2.11.3 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product and Solutions
2.11.4 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Kissei Pharmaceutical Co.Ltd. Recent Developments and Future Plans
2.12 Ruiyang Pharmaceutical Co., Ltd
2.12.1 Ruiyang Pharmaceutical Co., Ltd Details
2.12.2 Ruiyang Pharmaceutical Co., Ltd Major Business
2.12.3 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Solutions
2.12.4 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Ruiyang Pharmaceutical Co., Ltd Recent Developments and Future Plans
2.13 Chiesi Pharmaceutical (Shangai) Co., Ltd
2.13.1 Chiesi Pharmaceutical (Shangai) Co., Ltd Details
2.13.2 Chiesi Pharmaceutical (Shangai) Co., Ltd Major Business
2.13.3 Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Product and Solutions
2.13.4 Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Chiesi Pharmaceutical (Shangai) Co., Ltd Recent Developments and Future Plans
2.14 Fuhe Group
2.14.1 Fuhe Group Details
2.14.2 Fuhe Group Major Business
2.14.3 Fuhe Group Antiasthmatic Drug Product and Solutions
2.14.4 Fuhe Group Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Fuhe Group Recent Developments and Future Plans
2.15 Lunan Pharmaceutical Group Co., Ltd
2.15.1 Lunan Pharmaceutical Group Co., Ltd Details
2.15.2 Lunan Pharmaceutical Group Co., Ltd Major Business
2.15.3 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product and Solutions
2.15.4 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Lunan Pharmaceutical Group Co., Ltd Recent Developments and Future Plans
2.16 Chengdu Huayu Pharmaceutical Co., Ltd
2.16.1 Chengdu Huayu Pharmaceutical Co., Ltd Details
2.16.2 Chengdu Huayu Pharmaceutical Co., Ltd Major Business
2.16.3 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Solutions
2.16.4 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments and Future Plans
2.17 Kaifeng Kangnuo Pharmaceutical Co., Ltd
2.17.1 Kaifeng Kangnuo Pharmaceutical Co., Ltd Details
2.17.2 Kaifeng Kangnuo Pharmaceutical Co., Ltd Major Business
2.17.3 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Solutions
2.17.4 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments and Future Plans
2.18 Akorn Pharmaceutical Co.Ltd.
2.18.1 Akorn Pharmaceutical Co.Ltd. Details
2.18.2 Akorn Pharmaceutical Co.Ltd. Major Business
2.18.3 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product and Solutions
2.18.4 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Akorn Pharmaceutical Co.Ltd. Recent Developments and Future Plans
2.19 Boehringer Ingelheim Pharma GmbH&Co.KG
2.19.1 Boehringer Ingelheim Pharma GmbH&Co.KG Details
2.19.2 Boehringer Ingelheim Pharma GmbH&Co.KG Major Business
2.19.3 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product and Solutions
2.19.4 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments and Future Plans
2.20 Covis Pharmaceutical Inc
2.20.1 Covis Pharmaceutical Inc Details
2.20.2 Covis Pharmaceutical Inc Major Business
2.20.3 Covis Pharmaceutical Inc Antiasthmatic Drug Product and Solutions
2.20.4 Covis Pharmaceutical Inc Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Covis Pharmaceutical Inc Recent Developments and Future Plans
2.21 Roche
2.21.1 Roche Details
2.21.2 Roche Major Business
2.21.3 Roche Antiasthmatic Drug Product and Solutions
2.21.4 Roche Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Roche Recent Developments and Future Plans
3.1 Global Antiasthmatic Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Antiasthmatic Drug Players Market Share
3.2.2 Top 10 Antiasthmatic Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Antiasthmatic Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4.1 Global Antiasthmatic Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Antiasthmatic Drug Market Forecast by Type (2021-2026)
5.1 Global Antiasthmatic Drug Revenue Market Share by Application (2016-2021)
5.2 Antiasthmatic Drug Market Forecast by Application (2021-2026)
6.1 North America Antiasthmatic Drug Revenue by Type (2016-2026)
6.2 North America Antiasthmatic Drug Revenue by Application (2016-2026)
6.3 North America Antiasthmatic Drug Market Size by Country
6.3.1 North America Antiasthmatic Drug Revenue by Country (2016-2026)
6.3.2 United States Antiasthmatic Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Antiasthmatic Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Antiasthmatic Drug Market Size and Forecast (2016-2026)
7.1 Europe Antiasthmatic Drug Revenue by Type (2016-2026)
7.2 Europe Antiasthmatic Drug Revenue by Application (2016-2026)
7.3 Europe Antiasthmatic Drug Market Size by Country
7.3.1 Europe Antiasthmatic Drug Revenue by Country (2016-2026)
7.3.2 Germany Antiasthmatic Drug Market Size and Forecast (2016-2026)
7.3.3 France Antiasthmatic Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Antiasthmatic Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Antiasthmatic Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Antiasthmatic Drug Market Size and Forecast (2016-2026)
8.1 Asia-Pacific Antiasthmatic Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Antiasthmatic Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Antiasthmatic Drug Market Size by Region
8.3.1 Asia-Pacific Antiasthmatic Drug Revenue by Region (2016-2026)
8.3.2 China Antiasthmatic Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Antiasthmatic Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Antiasthmatic Drug Market Size and Forecast (2016-2026)
8.3.5 India Antiasthmatic Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Antiasthmatic Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Antiasthmatic Drug Market Size and Forecast (2016-2026)
9.1 South America Antiasthmatic Drug Revenue by Type (2016-2026)
9.2 South America Antiasthmatic Drug Revenue by Application (2016-2026)
9.3 South America Antiasthmatic Drug Market Size by Country
9.3.1 South America Antiasthmatic Drug Revenue by Country (2016-2026)
9.3.2 Brazil Antiasthmatic Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Antiasthmatic Drug Market Size and Forecast (2016-2026)
10.1 Middle East & Africa Antiasthmatic Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Antiasthmatic Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Antiasthmatic Drug Market Size by Country
10.3.1 Middle East & Africa Antiasthmatic Drug Revenue by Country (2016-2026)
10.3.2 Turkey Antiasthmatic Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Antiasthmatic Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Antiasthmatic Drug Market Size and Forecast (2016-2026)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Antiasthmatic Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Antiasthmatic Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Antiasthmatic Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Antiasthmatic Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Antiasthmatic Drug Revenue Market Share by Region (2021-2026)
Table 6. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 7. Novartis AG Major Business
Table 8. Novartis AG Antiasthmatic Drug Product and Solutions
Table 9. Novartis AG Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline Major Business
Table 12. GlaxoSmithKline Antiasthmatic Drug Product and Solutions
Table 13. GlaxoSmithKline Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. ABC Farmaceutici Spa Corporate Information, Head Office, and Major Competitors
Table 15. ABC Farmaceutici Spa Major Business
Table 16. ABC Farmaceutici Spa Antiasthmatic Drug Product and Solutions
Table 17. ABC Farmaceutici Spa Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 19. AstraZeneca Major Business
Table 20. AstraZeneca Antiasthmatic Drug Product and Solutions
Table 21. AstraZeneca Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Teva Pharmaceutical Industries Ltd Corporate Information, Head Office, and Major Competitors
Table 23. Teva Pharmaceutical Industries Ltd Major Business
Table 24. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product and Solutions
Table 25. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Mundipharma Pharmaceuticals Ltd. Corporate Information, Head Office, and Major Competitors
Table 27. Mundipharma Pharmaceuticals Ltd. Major Business
Table 28. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product and Solutions
Table 29. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. MSD Corporate Information, Head Office, and Major Competitors
Table 31. MSD Major Business
Table 32. MSD Antiasthmatic Drug Product and Solutions
Table 33. MSD Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Daiichi Sankyo Company Limited Corporate Information, Head Office, and Major Competitors
Table 35. Daiichi Sankyo Company Limited Major Business
Table 36. Daiichi Sankyo Company Limited Antiasthmatic Drug Product and Solutions
Table 37. Daiichi Sankyo Company Limited Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Chiesi GmbH Corporate Information, Head Office, and Major Competitors
Table 39. Chiesi GmbH Major Business
Table 40. Chiesi GmbH Antiasthmatic Drug Product and Solutions
Table 41. Chiesi GmbH Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Kyorin Pharmaceutical Co.,Ltd. Corporate Information, Head Office, and Major Competitors
Table 43. Kyorin Pharmaceutical Co.,Ltd. Major Business
Table 44. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product and Solutions
Table 45. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Kissei Pharmaceutical Co.Ltd. Corporate Information, Head Office, and Major Competitors
Table 47. Kissei Pharmaceutical Co.Ltd. Major Business
Table 48. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product and Solutions
Table 49. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Ruiyang Pharmaceutical Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 51. Ruiyang Pharmaceutical Co., Ltd Major Business
Table 52. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Solutions
Table 53. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Chiesi Pharmaceutical (Shangai) Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 55. Chiesi Pharmaceutical (Shangai) Co., Ltd Major Business
Table 56. Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Product and Solutions
Table 57. Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Fuhe Group Corporate Information, Head Office, and Major Competitors
Table 59. Fuhe Group Major Business
Table 60. Fuhe Group Antiasthmatic Drug Product and Solutions
Table 61. Fuhe Group Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Lunan Pharmaceutical Group Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 63. Lunan Pharmaceutical Group Co., Ltd Major Business
Table 64. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product and Solutions
Table 65. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Chengdu Huayu Pharmaceutical Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 67. Chengdu Huayu Pharmaceutical Co., Ltd Major Business
Table 68. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Solutions
Table 69. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Kaifeng Kangnuo Pharmaceutical Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 71. Kaifeng Kangnuo Pharmaceutical Co., Ltd Major Business
Table 72. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Solutions
Table 73. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Akorn Pharmaceutical Co.Ltd. Corporate Information, Head Office, and Major Competitors
Table 75. Akorn Pharmaceutical Co.Ltd. Major Business
Table 76. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product and Solutions
Table 77. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Boehringer Ingelheim Pharma GmbH&Co.KG Corporate Information, Head Office, and Major Competitors
Table 79. Boehringer Ingelheim Pharma GmbH&Co.KG Major Business
Table 80. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product and Solutions
Table 81. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Covis Pharmaceutical Inc Corporate Information, Head Office, and Major Competitors
Table 83. Covis Pharmaceutical Inc Major Business
Table 84. Covis Pharmaceutical Inc Antiasthmatic Drug Product and Solutions
Table 85. Covis Pharmaceutical Inc Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Roche Corporate Information, Head Office, and Major Competitors
Table 87. Roche Major Business
Table 88. Roche Antiasthmatic Drug Product and Solutions
Table 89. Roche Antiasthmatic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Global Antiasthmatic Drug Revenue (USD Million) by Players (2019-2021)
Table 91. Global Antiasthmatic Drug Revenue Share by Players (2019-2021)
Table 92. Breakdown of Antiasthmatic Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Antiasthmatic Drug Players Head Office, Products and Services Provided
Table 94. Antiasthmatic Drug Mergers & Acquisitions in the Past Five Years
Table 95. Antiasthmatic Drug New Entrants and Expansion Plans
Table 96. Global Antiasthmatic Drug Revenue (USD Million) by Type (2016-2021)
Table 97. Global Antiasthmatic Drug Revenue Share by Type (2016-2021)
Table 98. Global Antiasthmatic Drug Revenue Forecast by Type (2021-2026)
Table 99. Global Antiasthmatic Drug Revenue by Application (2016-2021)
Table 100. Global Antiasthmatic Drug Revenue Forecast by Application (2021-2026)
Table 101. North America Antiasthmatic Drug Revenue by Type (2016-2021) & (USD Million)
Table 102. North America Antiasthmatic Drug Revenue by Type (2021-2026) & (USD Million)
Table 103. North America Antiasthmatic Drug Revenue by Application (2016-2021) & (USD Million)
Table 104. North America Antiasthmatic Drug Revenue by Application (2021-2026) & (USD Million)
Table 105. North America Antiasthmatic Drug Revenue by Country (2016-2021) & (USD Million)
Table 106. North America Antiasthmatic Drug Revenue by Country (2021-2026) & (USD Million)
Table 107. Europe Antiasthmatic Drug Revenue by Type (2016-2021) & (USD Million)
Table 108. Europe Antiasthmatic Drug Revenue by Type (2021-2026) & (USD Million)
Table 109. Europe Antiasthmatic Drug Revenue by Application (2016-2021) & (USD Million)
Table 110. Europe Antiasthmatic Drug Revenue by Application (2021-2026) & (USD Million)
Table 111. Europe Antiasthmatic Drug Revenue by Country (2016-2021) & (USD Million)
Table 112. Europe Antiasthmatic Drug Revenue by Country (2021-2026) & (USD Million)
Table 113. Asia-Pacific Antiasthmatic Drug Revenue by Type (2016-2021) & (USD Million)
Table 114. Asia-Pacific Antiasthmatic Drug Revenue by Type (2021-2026) & (USD Million)
Table 115. Asia-Pacific Antiasthmatic Drug Revenue by Application (2016-2021) & (USD Million)
Table 116. Asia-Pacific Antiasthmatic Drug Revenue by Application (2021-2026) & (USD Million)
Table 117. Asia-Pacific Antiasthmatic Drug Revenue by Region (2016-2021) & (USD Million)
Table 118. Asia-Pacific Antiasthmatic Drug Revenue by Region (2021-2026) & (USD Million)
Table 119. South America Antiasthmatic Drug Revenue by Type (2016-2021) & (USD Million)
Table 120. South America Antiasthmatic Drug Revenue by Type (2021-2026) & (USD Million)
Table 121. South America Antiasthmatic Drug Revenue by Application (2016-2021) & (USD Million)
Table 122. South America Antiasthmatic Drug Revenue by Application (2021-2026) & (USD Million)
Table 123. South America Antiasthmatic Drug Revenue by Country (2016-2021) & (USD Million)
Table 124. South America Antiasthmatic Drug Revenue by Country (2021-2026) & (USD Million)
Table 125. Middle East & Africa Antiasthmatic Drug Revenue by Type (2016-2021) & (USD Million)
Table 126. Middle East & Africa Antiasthmatic Drug Revenue by Type (2021-2026) & (USD Million)
Table 127. Middle East & Africa Antiasthmatic Drug Revenue by Application (2016-2021) & (USD Million)
Table 128. Middle East & Africa Antiasthmatic Drug Revenue by Application (2021-2026) & (USD Million)
Table 129. Middle East & Africa Antiasthmatic Drug Revenue by Country (2016-2021) & (USD Million)
Table 130. Middle East & Africa Antiasthmatic Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Antiasthmatic Drug Picture
Figure 2. Global Antiasthmatic Drug Revenue Market Share by Way of Action in 2020
Figure 3. Bronchodilators
Figure 4. Anti-allergic Antiasthmatic
Figure 5. Anti-inflammatory Antiasthmatic
Figure 6. Antiasthmatic Drug Revenue Market Share by Application in 2020
Figure 7. Need for Acute Attack of Asthma Picture
Figure 8. Treatment of Chronic Asthma Picture
Figure 9. Global Antiasthmatic Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Antiasthmatic Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Antiasthmatic Drug Revenue Market Share by Region (2016-2026)
Figure 12. Global Antiasthmatic Drug Revenue Market Share by Region in 2020
Figure 13. North America Antiasthmatic Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Antiasthmatic Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Antiasthmatic Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Antiasthmatic Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Antiasthmatic Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Antiasthmatic Drug Market Drivers
Figure 19. Antiasthmatic Drug Market Restraints
Figure 20. Antiasthmatic Drug Market Trends
Figure 21. Novartis AG Recent Developments and Future Plans
Figure 22. GlaxoSmithKline Recent Developments and Future Plans
Figure 23. ABC Farmaceutici Spa Recent Developments and Future Plans
Figure 24. AstraZeneca Recent Developments and Future Plans
Figure 25. Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
Figure 26. Mundipharma Pharmaceuticals Ltd. Recent Developments and Future Plans
Figure 27. MSD Recent Developments and Future Plans
Figure 28. Daiichi Sankyo Company Limited Recent Developments and Future Plans
Figure 29. Chiesi GmbH Recent Developments and Future Plans
Figure 30. Kyorin Pharmaceutical Co.,Ltd. Recent Developments and Future Plans
Figure 31. Kissei Pharmaceutical Co.Ltd. Recent Developments and Future Plans
Figure 32. Ruiyang Pharmaceutical Co., Ltd Recent Developments and Future Plans
Figure 33. Chiesi Pharmaceutical (Shangai) Co., Ltd Recent Developments and Future Plans
Figure 34. Fuhe Group Recent Developments and Future Plans
Figure 35. Lunan Pharmaceutical Group Co., Ltd Recent Developments and Future Plans
Figure 36. Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments and Future Plans
Figure 37. Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments and Future Plans
Figure 38. Akorn Pharmaceutical Co.Ltd. Recent Developments and Future Plans
Figure 39. Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments and Future Plans
Figure 40. Covis Pharmaceutical Inc Recent Developments and Future Plans
Figure 41. Roche Recent Developments and Future Plans
Figure 42. Global Antiasthmatic Drug Revenue Share by Players in 2020
Figure 43. Antiasthmatic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 44. Global Top 3 Players Antiasthmatic Drug Revenue Market Share in 2020
Figure 45. Global Top 10 Players Antiasthmatic Drug Revenue Market Share in 2020
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 47. Global Antiasthmatic Drug Revenue Share by Type in 2020
Figure 48. Global Antiasthmatic Drug Market Share Forecast by Type (2021-2026)
Figure 49. Global Antiasthmatic Drug Revenue Share by Application in 2020
Figure 50. Global Antiasthmatic Drug Market Share Forecast by Application (2021-2026)
Figure 51. North America Antiasthmatic Drug Sales Market Share by Type (2016-2026)
Figure 52. North America Antiasthmatic Drug Sales Market Share by Application (2016-2026)
Figure 53. North America Antiasthmatic Drug Revenue Market Share by Country (2016-2026)
Figure 54. United States Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Canada Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Mexico Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Europe Antiasthmatic Drug Sales Market Share by Type (2016-2026)
Figure 58. Europe Antiasthmatic Drug Sales Market Share by Application (2016-2026)
Figure 59. Europe Antiasthmatic Drug Revenue Market Share by Country (2016-2026)
Figure 60. Germany Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. France Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. United Kingdom Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Russia Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Italy Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Asia-Pacific Antiasthmatic Drug Sales Market Share by Type (2016-2026)
Figure 66. Asia-Pacific Antiasthmatic Drug Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Antiasthmatic Drug Revenue Market Share by Region (2016-2026)
Figure 68. China Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Japan Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South Korea Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. India Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Southeast Asia Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Australia Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South America Antiasthmatic Drug Sales Market Share by Type (2016-2026)
Figure 75. South America Antiasthmatic Drug Sales Market Share by Application (2016-2026)
Figure 76. South America Antiasthmatic Drug Revenue Market Share by Country (2016-2026)
Figure 77. Brazil Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Argentina Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Middle East and Africa Antiasthmatic Drug Sales Market Share by Type (2016-2026)
Figure 80. Middle East and Africa Antiasthmatic Drug Sales Market Share by Application (2016-2026)
Figure 81. Middle East and Africa Antiasthmatic Drug Revenue Market Share by Country (2016-2026)
Figure 82. Turkey Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Saudi Arabia Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. UAE Antiasthmatic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novartis AG GlaxoSmithKline ABC Farmaceutici Spa AstraZeneca Teva Pharmaceutical Industries Ltd Mundipharma Pharmaceuticals Ltd. MSD Daiichi Sankyo Company Limited Chiesi GmbH Kyorin Pharmaceutical Co.,Ltd. Kissei Pharmaceutical Co.Ltd. Ruiyang Pharmaceutical Co., Ltd Chiesi Pharmaceutical (Shangai) Co., Ltd Fuhe Group Lunan Pharmaceutical Group Co., Ltd Chengdu Huayu Pharmaceutical Co., Ltd Kaifeng Kangnuo Pharmaceutical Co., Ltd Akorn Pharmaceutical Co.Ltd. Boehringer Ingelheim Pharma GmbH&Co.KG Covis Pharmaceutical Inc Roche
Related Reports
19 Jan 2022
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
